Reduction of non-Betalactam Antibiotics COD by Combined Coagulation and Advanced Oxidation Processes
The present study evaluates the reduction of antibiotic COD from wastewater by combined coagulation and advanced oxidation processes (AOPS). The reduction of Azithromycin COD by combined coagulation and Fenton-like processes reached a maximum 96.9% at a reaction time of 30 min, dosage of ferric ch...
| Veröffentlicht in: | Water environment research : a research publication of the Water Environment Federation. - 1998. - 88(2016), 11 vom: 01. Nov., Seite 2121-2131 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , , , , , |
| Format: | Online-Aufsatz |
| Sprache: | English |
| Veröffentlicht: |
2016
|
| Zugriff auf das übergeordnete Werk: | Water environment research : a research publication of the Water Environment Federation |
| Schlagworte: | Journal Article Anti-Bacterial Agents Azithromycin 83905-01-5 Hydrogen Peroxide BBX060AN9V Iron E1UOL152H7 Clarithromycin H1250JIK0A |
| Zusammenfassung: | The present study evaluates the reduction of antibiotic COD from wastewater by combined coagulation and advanced oxidation processes (AOPS). The reduction of Azithromycin COD by combined coagulation and Fenton-like processes reached a maximum 96.9% at a reaction time of 30 min, dosage of ferric chloride 120 mg/L, dosages of Fe0 and H2O2of 0.36mM/L and 0.38 mM/L, respectively. Also, 97.9% of Clarithromycin COD reduction, was achieved at a reaction time of 30 min, dosage of ferric chloride 120 mg/L, dosages of Fe0 and H2O2 of 0.3 mM/L and 0.3mM/L, respectively. The results of kinetic studies were best fitted to the pseudo first order equation. The results showed a higher rate constant value for combined coagulation and Fenton-like processes [(kap = 0.022 min-1 and half-life time of 31.5 min for Azithromycin) and (kap = 0.023 min-1 and half-life time of 30.1 min for Clarithromycin)] |
|---|---|
| Beschreibung: | Date Completed 03.08.2017 Date Revised 03.08.2017 published: Print Citation Status MEDLINE |
| ISSN: | 1554-7531 |
| DOI: | 10.2175/106143016X14733681695447 |